A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 14, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Primary Biliary Cholangitis (PBC)

Interventions

DRUG

Fenofibrate

Fenofibrate 200mg/day

DRUG

UDCA (Ursodeoxycholic acid)

UDCA 13-15mg/kg/day

Trial Locations (1)

Xijing hospital, Xi'an

All Listed Sponsors

lead

Han Ying

OTHER